Delivery Order SPE2DB20D9127-SPE2DB25FPRC0
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $19,316.57 by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Trikafta 100-50-75 mg/75 mg packets in quantities of 14. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, was issued without a set-aside designation. The contract represents a continuation of DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on August 5, 2025. The delivery order, which expires August 6, 2025, is for Trikafta 100-50-75 mg/150 mg pharmaceutical products. This award was issued without a set-aside designation and represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $19,314.19 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 80-40-60mg/59.5mg packets in quantities of 14. The contract is firm fixed-price with no set-aside designation, and is scheduled for ultimate completion by August 13, 2025, one day after the award date of August 12, 2025. This delivery order falls under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $18,488.12 by the Defense Logistics Agency for Trikafta 100-50-75 mg/150 mg tablets (84 units). This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a direct pharmaceutical supply fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $36,976.24 by the Defense Logistics Agency (DLA) on July 31, 2025, with an ultimate completion date of August 1, 2025. The delivery order, issued under a firm fixed-price contract structure with no set-aside designation, covers the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). Performance will occur at the contractor's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on August 8, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The delivery order carries an ultimate completion date of August 11, 2025, and involves no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing single-award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $19,314.19 by the Defense Logistics Agency (DLA) on July 18, 2025, for the supply of Trikafta 80-40-60mg/59.5mg packets (14-count). This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a continuation of DMS Pharmaceutical Group's role as a critical pharmaceutical supplier to the federal...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Trikafta 100-50-75 mg/75 mg packets in quantities of 14. This firm fixed-price delivery order, valued at $37,804.69, was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The award carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on July 28, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The order, which carries an ultimate completion date of July 29, 2025, represents a standard pharmaceutical supply transaction without set-aside designation. This delivery order is issued under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,488.12 by the Defense Logistics Agency on August 13, 2025, for the supply of Trikafta 100-50-75 mg/150 mg medications. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a direct pharmaceutical supply to support Department of Defense healthcare operations. The contract was awarded without...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB25FPRC0Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $77,266.28 by the Defense Logistics Agency on August 12, 2025, for the supply of Trikafta 100-50-75 mg/75 mg packets in quantities of 14 units. The delivery order, which carries a firm fixed-price structure with no set-aside designation, is scheduled for completion by August 13, 2025, and will be fulfilled from the company's Park Ridge facility. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026. DMS Pharmaceutical Group's substantial IDC with the Defense Logistics Agency under the SPE2DB program enables the agency to procure a comprehensive range of pharmaceutical products to support military healthcare facilities worldwide. The company's federal procurement portfolio demonstrates consistent success in delivering branded and generic prescription medications, biologics, and medical consumables to Department of Defense healthcare sites. This particular delivery order for Trikafta, a prescription medication used in treating cystic fibrosis, reflects the company's role as a critical supplier within the federal pharmaceutical supply chain serving military health system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $77.3k | 8/12/25 |